secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001628280-25-048516
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem Q3 2025 revenue $36.5M (+3% YoY), net income $2.3M (+25%), reaffirms 2025 guidance
--------------------------------------------------------------------------------

- Net revenues $36.5M (record), up 3% vs. $35.3M a year ago; Patient Services up 8%, Device Solutions down 3%.
- Net income $2.3M ($0.11 diluted EPS) vs. $1.8M ($0.08) prior year, a 25% increase.
- Adjusted EBITDA $8.3M (+6%), margin 22.8% (up 0.5pp); YTD operating cash flow $17.3M (+38%).
- Wound care revenue surged 115% YoY ($1.0M); new contract with large hospital system and payer extension secured.
- Reaffirms full-year 2025 guidance: net revenue growth 6-8%, Adjusted EBITDA margin 20%+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025048516/0001628280-25-048516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828025048516/infu-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-048516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer